Samuel M Silver, MD, PhD, MACP
Clinical Professor Emeritus of Internal Medicine
[email protected]

Available to mentor
Samuel M Silver, MD, PhD, MACP
Clinical Professor Emeritus/a
  • Center Memberships
  • Recent Publications
    • Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Recent Publications See All Publications
    • Journal Article
      Cancer Biosimilars-A Regulatory Success So Far, but Value Still to Be Determined.
      Blayney DW, Silver SM. JAMA Oncol, 2022 Apr 1; 8 (4): 520 - 521. DOI:10.1001/jamaoncol.2021.6979
      PMID: 35113156
    • Proceeding / Abstract / Poster
      REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS DIAGNOSED WITH ERYTHROPOIETIC PROTOPORPHYRIA AND X-LINKED PROTOPORPHYRIA: RESULTS FROM A US ELECTRONIC MEDICAL RECORDS STUDY
      Ciepielewska M, Hagan M, Houghton K, Hitchens A, Ansquer V, Silver SM. VALUE IN HEALTH, 2022 25 (7): S496 - S496.
    • Journal Article
      Eighteen-Month Interim Analysis of Efficacy and Safety of Givosiran, an RNAi Therapeutic for Acute Hepatic Porphyria, in the Envision Open Label Extension
      Kuter DJ, Keel S, Parker CJ, Rees DC, Stölzel U, Ventura P, Balwani M, Gouya L, Simon A, Liu S, Ko JJ, Rhyee S, Silver SM. Blood, 2020 Nov 5; 136 (Supplement 1): 13 DOI:10.1182/blood-2020-134564
    • Journal Article
      Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria.
      Balwani M, Sardh E, Ventura P, Peiró PA, Rees DC, Stölzel U, Bissell DM, Bonkovsky HL, Windyga J, Anderson KE, Parker C, Silver SM, Keel SB, Wang J-D, Stein PE, Harper P, Vassiliou D, Wang B, Phillips J, Ivanova A, Langendonk JG, Kauppinen R, Minder E, Horie Y, Penz C, Chen J, Liu S, Ko JJ, Sweetser MT, Garg P, Vaishnaw A, Kim JB, Simon AR, Gouya L, ENVISION Investigators . N Engl J Med, 2020 Jun 11; 382 (24): 2289 - 2301. DOI:10.1056/NEJMoa1913147
      PMID: 32521132
    • Proceeding / Abstract / Poster
      HEALTHCARE UTILIZATION AND COSTS AMONG PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA RECEIVING HEMIN: ANALYSES FROM A NATIONAL HEALTHCARE DATABASE
      Erwin AL, Silver SM, Meninger S, Tkacz J, Noxon V, Ko JJ. VALUE IN HEALTH, 2020 23: S348 - S348.
    • Journal Article
      Cutaneous and laryngopharyngeal papules of xanthoma disseminatum successfully treated with 2-chlorodeoxyadenosine.
      Briones NF, Hogikyan ND, Fullen DR, Silver SM, Do TT. JAAD Case Rep, 2018 Nov; 4 (10): 990 - 992. DOI:10.1016/j.jdcr.2018.09.020
      PMID: 30417060
    • Journal Article
      The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.
      Caughran J, Braun TM, Breslin TM, Smith DR, Kreinbrink JL, Parish GK, Davis AT, Bacon-Baguley TA, Silver SM, Henry NL. Breast J, 2018 Sep; 24 (5): 730 - 737. DOI:10.1111/tbj.13034
      PMID: 29785764
    • Journal Article
      The devil's in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda.
      Sunkara B, Roofeh D, Silver S, Pearson TL, Ettel M, McCune WJ. Lupus, 2018 Jul; 27 (8): 1383 - 1386. DOI:10.1177/0961203318768884
      PMID: 29631513